Pharmacological treatment of gastroesophageal reflux disease
Abstract
Introduction Gastroesophageal reflux disease (GERD) is a chronic pathology characterized by the return of gastric contents toward the esophagus, which produces bothersome symptoms such as heartburn and regurgitation, affects quality of life, and may lead to complications1–3. Pharmacological treatment is the basis of its management, especially in moderate to severe forms of the disease3,4. Therapeutic […]
Read the paper
Related studies
- Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
- Treatment and prognostic factors for long-term outcome in patients with anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis: a cohort study
- Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study
- Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study
- Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank
- Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.